• Pulmonary Arterial Remodeling and RV Afterload

  2026-08-20

  This 2025 study uses a subject-specific one-dimensional fluid–structure interaction model to separate how distal pulmonary vascular resistance and proximal arterial compliance shape right ventricular afterload in pulmonary hypertension. Its central finding is that increased distal resistance most strongly raises maximum main pulmonary artery pressure, whereas reduced compliance substantially increases characteristic impedance, providing a mechanistic basis for more targeted interpretation of pulmonary hemodynamics.

• L. reuteri FN041 Remodels Colitis-Linked Microbiota

  2026-08-20

  This study shows that human milk-derived Limosilactobacillus reuteri FN041 reduces disease severity in DSS-induced colitis mice while improving barrier-associated, inflammatory, microbial, and metabolic readouts. Its main contribution is an integrated multi-omics view of probiotic activity, although the findings remain preclinical and do not establish causality or clinical efficacy in ulcerative colitis.

• Galectin-1, FIP200, and Autophagy in Hepatic Steatosis

  2026-08-19

  The reference study identifies a Galectin-1–FIP200 interaction as an upstream mechanism that suppresses autophagy and links hepatic steatosis with insulin resistance. Its combination of in vivo metabolic phenotyping, proteomic analysis, interaction mapping, and interface-disrupting mutations provides a useful framework for studying autophagy control in metabolic liver disease.

• Measuring Cancer Drug Response Beyond Viability

  2026-08-19

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent features of anticancer drug response. This framework offers a more rigorous way to interpret in vitro results and to design follow-up studies, including hepatocellular carcinoma models involving agents such as Salinomycin.

• Uremic Metabolite Adsorption on Hydroxy-PEO Films

  2026-08-18

  The 2025 reference study examines how hydroxy-terminated polyethylene oxide (PEO) surfaces interact with a multi-component mixture of uremic metabolites, addressing a major gap left by single-solute adsorption experiments. Its results show that PEO chain density, exposure time, end-group chemistry, and metabolite structure jointly determine adsorption, with important implications for blood-contacting biomaterials designed for kidney failure conditions.

• UTP Solution (100 mM) for RNA Workflows

  2026-08-18

  UTP Solution is a high-purity Uridine-5'-triphosphate trisodium salt preparation for RNA synthesis and nucleotide-dependent assays. Its defined 100 mM concentration, RNase/DNase-free specification, and frozen storage guidance support reproducible molecular biology workflows.

• Deferasirox in Reliable Cell Viability Assays

  2026-08-17

  Learn how Deferasirox (SKU A8639) can support reproducible iron-dependent viability, proliferation, and cytotoxicity studies. This scenario-based guide covers oxygen-sensitive dosing, solvent controls, assay interpretation, and practical supplier selection with links to product data and recent lysosomal cell-death research.

• Cy5 TSA Fluorescence System Kit for Atherosclerosis

  2026-08-17

  The Cy5 TSA Fluorescence System Kit turns weak immunostaining and in situ hybridization signals into high-contrast spatial data, making it useful for mapping inflammatory targets in atherosclerotic tissue. This guide connects horseradish peroxidase-based amplification with practical assay design, quantitative imaging, and troubleshooting for low-abundance biomarkers.

• Trypsin-Responsive Nanomedicine for Acute Pancreatitis

  2026-08-16

  This ACS Nano study presents a biomimetic mesoporous organosilica system that targets injured pancreatic acinar cells and releases BAPTA-AM after trypsin-mediated scaffold cleavage. In mouse acute pancreatitis models, the formulation reduced calcium overload, inflammatory signaling, pancreatic enzyme elevation, and mortality, while illustrating how disease-specific enzymatic triggers can improve intracellular drug delivery.

• v-Agatoxin-IVA and Neuronal Ca Channel Selectivity

  2026-08-15

  Sidach and Mintz showed that v-Agatoxin-IVA remains a high-affinity P-type calcium channel blocker but can also inhibit N-type currents at micromolar exposure. The study demonstrates why toxin concentration, native neuronal context, and voltage dependence must be considered before using v-Aga-IVA to distinguish P- and Q-type channels.

• 25-Hydroxycholesterol Reprograms Immunosuppressive TAMs

  2026-08-14

  Xiao et al. identify CH25H-derived 25-hydroxycholesterol (25HC) as an immunometabolic checkpoint that links lysosomal sterol accumulation to AMPKα–STAT6 signaling and ARG1 production in tumor-associated macrophages. The study provides a mechanistic rationale for targeting CH25H to improve macrophage-mediated tumor immunity and enhance responses to anti-PD-1 therapy.

• CK2 and ERK8 Inhibitor: Assay Design Guide

  2026-08-14

  Explore how the 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid small molecule inhibitor can clarify kinase-dependent signaling and biomolecular-condensate assays. This guide connects B7464 with SARS-CoV-2 nucleocapsid phase-separation research while defining evidence-based experimental boundaries.

• Sulfo-Cy5 Carboxylic Acid for Translation

  2026-08-13

  Translational researchers need more than a bright signal: they need evidence that localization, persistence, and biological effect are connected. This thought-leadership article examines Sulfo-Cy5 carboxylic acid as a fluorescent dye for life sciences and develops a practical validation strategy for nanoparticle vaccine, mucosal immunity, and protein and peptide labeling workflows.

• Gramine Workflow for Ferroptosis Research

  2026-08-13

  Gramine is a mechanism-forward small molecule for connecting TNBC growth inhibition with ferroptosis, MTDH regulation, and CUL3 activity. This practical workflow covers formulation, dose-response design, target-engagement assays, rescue experiments, and troubleshooting for reproducible cancer biology research.

• Imipenem in Carbapenem Resistance Research

  2026-08-12

  Imipenem connects mechanism-driven antibacterial research with practical resistance, plasmid-transfer, and immune-response workflows. This guide shows how to formulate, test, validate, and troubleshoot Imipenem assays while keeping phenotype data aligned with carbapenemase genetics.

16813 records 1/1121 page Next 12345 下5页 Last page